Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. | J Hematol Oncol | 2022 | 36031601 | PubTator, text mining | PubMed |
| Next Steps for Immunotherapy in Glioblastoma. | Cancers (Basel) | 2022 | 36011015 | PubTator, text mining | PubMed |
| Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas. | Cancers (Basel) | 2022 | 36010978 | PubTator, text mining | PubMed |
| Novel Necroptosis-Related Gene Signature for Predicting Early Diagnosis and Prognosis and Immunotherapy of Gastric Cancer. | Cancers (Basel) | 2022 | 36010886 | PubTator, text mining | PubMed |
| Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. | Front Cell Dev Biol | 2022 | 36003146 | PubTator, text mining | PubMed |
| X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer. | Front Genet | 2022 | 35991556 | PubTator, text mining | PubMed |
| m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer. | J Immunol Res | 2022 | 35991123 | PubTator, text mining | PubMed |
| Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies. | Technol Cancer Res Treat | 2022 | 35989682 | PubTator, text mining | PubMed |
| Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140. | BMC Biol | 2022 | 35986286 | PubTator, text mining | PubMed |
| Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer. | Front Immunol | 2022 | 35983060 | PubTator, text mining | PubMed |
| Serological biomarkers in autoimmune GFAP astrocytopathy. | Front Immunol | 2022 | 35983033 | PubTator, text mining | PubMed |
| Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme. | Front Oncol | 2022 | 35982954 | PubTator, text mining | PubMed |
| Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation. | ACS Nano | 2022 | 35969506 | PubTator, text mining | PubMed |
| The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment. | Front Immunol | 2022 | 35967381 | PubTator, text mining | PubMed |
| Stem Cell Therapy and Innate Lymphoid Cells. | Stem Cells Int | 2022 | 35958032 | PubTator, text mining | PubMed |
| Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma. | Nanomaterials (Basel) | 2022 | 35957076 | PubTator, text mining | PubMed |
| CAR-NK Cells: A Chimeric Hope or a Promising Therapy? | Cancers (Basel) | 2022 | 35954502 | PubTator, text mining | PubMed |
| Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. | Cancers (Basel) | 2022 | 35954362 | PubTator, text mining | PubMed |
| Sex-specific transcriptome differences in a middle-aged frailty cohort. | BMC Geriatr | 2022 | 35945487 | PubTator, text mining | PubMed |
| Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer. | J Immunol Res | 2022 | 35942212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=42